1

*
Inflammatory CD4
+ T cell responses to self or commensal bacteria underlie the pathogenesis of autoimmunity and inflammatory bowel disease (IBD), respectively. Although selection of self-specific T cells in the thymus limits responses to mammalian tissue antigens, the mechanisms that control selection of commensal bacteria-specific T cells remain poorly understood. Here, we demonstrate that group 3 innate lymphoid cell (ILC3)-intrinsic expression of major histocompatibility complex class II (MHCII) is regulated similarly to thymic epithelial cells and that MHCII + ILC3s directly induce cell death of activated commensal bacteria-specific T cells. Further, MHCII on colonic ILC3s was reduced in pediatric IBD patients. Collectively, these results define a selection pathway for commensal bacteria-specific CD4 + T cells in the intestine and suggest that this process is dysregulated in human IBD.
P athologic CD4
+ T cell responses to self are limited by presentation of self-antigens in the thymus on major histocompatibility complex class II-positive (MHCII + ) thymic epithelial cells (TECs) and dendritic cells (DCs), resulting in clonal deletion (1) (2) (3) (4) (5) (6) . In contrast, commensal bacteria-specific CD4 + T cells, which have been implicated in the pathogenesis of inflammatory bowel disease (IBD) (7) (8) (9) (10) (11) , do not encounter cognate antigen in the thymus and therefore are not subject to negative selection before entering the periphery (12, 13) . Although physical and biochemical barriers separate the immune system from intestinal commensal bacteria (7, (13) (14) (15) (16) (17) , antigens derived from commensal bacteria are continuously sampled from the intestinal lumen and presented by DCs in the draining lymph nodes (7, 10, 15, 18, 19) . Regulatory T cells (T reg ) can in part limit dysregulated CD4 + T cell responses to commensal bacteria (20, 21) . However, whether other mechanisms control commensal bacteria-specific CD4 + T cells in lieu of thymic negative selection is poorly defined. In recent studies, group 3 innate lymphoid cells (ILC3s) were found to express MHCII, and genetic deletion of ILC3-intrinsic MHCII resulted in spontaneous CD4 + T celldependent intestinal inflammation (22) , suggesting that additional antigen-presentation pathways control commensal bacteria-specific CD4 + T cell populations. CCR6-expressing lymphoid tissue inducer (LTi)-like ILC3s (CCR6 + ILC3s) are a major ILC subset present in the mesenteric lymph node (mLN) (Fig. 1A) S1E ) (25) . Further, in contrast to a recent report (26) , expression of MHCII, CD80, and CD86 on CCR6 + ILC3s was unaffected by ex vivo stimulation with microbial or inflammatory stimuli or by the absence of MyD88 or Caspase 1/11 in vivo ( fig. S2) .
Next, we examined whether expression of ILC3-intrinsic MHCII was dependent on the class II transactivator (CIITA), a master transcriptional regulator of MHCII expression (27) . MHCII expression was absent on both CCR6 + ILC3s and canonical antigen-presenting cells from Ciita −/− mice, relative to Ciita +/+ control mice (Fig. 1B  and fig. S3A ). Transcription of CIITA in mice is driven via distinct promoter elements-termed pI, pIII, and pIV-that are indicative of the upstream signaling events that induce MHCII expression (27) . In contrast to B cells and DCs, CCR6 + ILC3-intrinsic MHCII expression was absent in the mLN of both pIII/pIV −/− and pIV −/− mice ( Fig. 1C and fig. S3 , B and C), indicating that the pIV promoter of Ciita is required for MHCII expression on CCR6 + ILC3s. The pIV promoter of Ciita is used by multiple cell types, such as epithelial cells, in response to interferon (IFN)-g signaling (27) . However, expression of MHCII on CCR6 + ILC3s was not impaired in the absence of IFN-g, IFN-gR1, or STAT-1 ( Fig. 1D and fig. S3 , D and E). MHCII expression in TECs was also dependent on the pIV promoter of Ciita ( fig. S3 , A and B), and pIV-dependent, IFN-g-independent CIITA expression has previously only been described in TECs (27) (28) (29) , suggesting a previously unappreciated link between ILC3s and TECs.
These data provoked the hypothesis that TECs and MHCII + ILC3s may share similar . All data are representative of at least four independent experiments with n = 2 to 3 mice per group. Results are shown as the mean T SEM. *P < 0.05; **P < 0.01; ***P < 0.001 (two-tailed Student's t test).
detected in the cLPL but not in the thymus ( fig.  S4C ). Further, sort-purified CD4 + T cells from MHCII DILC3 mice responded to fecal-derived antigen but not mammalian tissue-derived antigens ( fig. S4D ). These data, along with previous studies (20, 30, 31) , suggest that the majority of CD4 + T cells in the steady-state intestine are specific for commensal bacteria and that ILC3-intrinsic MHCII controls commensal bacteria-specific CD4 + T cell responses through direct presentation of microbiota-derived antigens. To test this, we crossed MHCII DILC3 mice with either TCR transgenic mice specific for CBir1, an antigen expressed by
Clostridia species constitutively present in the murine and human microbiota (13, 32) , or TCR transgenic mice specific for ovalbumin (OT-II). Loss of ILC3-intrinsic MHCII had no effect on the frequencies or cell numbers of OT-II or CBir1 T cells in the thymus (Fig. 2A) . In contrast, numbers of CBir1, but not OT-II, T cells were increased In vitro assay data are representative of at least two to three independent experiments, with two to three biological replicates per experiment. Array data are representative of a single experiment with four biological replicates. All in vivo data are representative of at least two independent experiments with at least n = 3 mice per group. Results are shown as the mean T SEM. *P < 0.05; **P < 0.01; ***P < 0.001 (two-tailed students t test).
in the cLPL and mLN (Fig. 2B and fig. S5A ), and CBir1 MHCIIDILC3 mice exhibited increased frequencies of antigen-specific IFN-g + and tumor necrosis factor (TNF)-a + colonic CD4 + T cells, colonic inflammation, and neutrophil infiltration, which could be prevented by administration of antibiotics (ABX) and was not observed in Rag1 −/− MHCII DILC3 mice (Fig. 2B-D and fig. S5A-D) . Finally, similar to polyclonal MHCII DILC3 mice, the population expansion and increased cytokine production of CBir1 CD4 + T cells were associated with a selective increase in CD44 hi CD62L lo T eff , whereas numbers of FoxP3 + T reg remained unchanged ( fig. S5E ). These data suggest that CCR6 + ILC3s selectively limit the expansion of commensal bacteria-specific CD4 + effector T cells through presentation of antigen derived from the endogenous microbiota. In support of this hypothesis and consistent with recent findings (33), MHCII + ILC3s localized in distinct clusters in the mLN at the interface between the B and T cell zones in the marginal and subcapsular sinus (Fig. 2E) , a site through which antigen-experienced T cells traffic.
To investigate the in vivo mechanisms through which MHCII + ILC3s control commensal bacteriaspecific CD4 + T cells, mice were generated in which MHCII expression was restricted to only ILC3s (Fig. 2F) + T cells in the mLN (Fig. 2 , H and I), which was due to a selective decrease in effector, but not regulatory CBir1 T cells (Fig.  2I) . MHCII + ILC3-mediated effects were antigenspecific, could be driven by endogenous microbiotaderived antigen alone, and were specific to ILC3s ( fig. S6, B to D, and fig. S7 ). Further, in complementary loss-of-function studies, adoptively transferred CBir1 CD4 + T eff expanded at higher frequencies and numbers in the mLN and cLPL of mice lacking ILC3-intrinsic MHCII (MHCII DILC3 mice), despite exhibiting comparable proliferation ( fig. S8 ). Finally, in line with ILC3-mediated control of antigen-experienced T cells, the frequency and number of activated CBir1 CD4 + T cells reaching the small intestine lamina propria (siLPL) and cLPL of MHCII ILC3+ mice were significantly decreased relative to MHCII neg controls (Fig. 2, J ILC3s resulted in a significant reduction in T cell numbers after culture in the presence of cognate antigen, which could be reversed by administration of an MHCII-blocking antibody (Fig. 3A) . Reduced cell recovery was associated with an antigen and MHCII-dependent increase in Caspase-3 activation (Fig. 3B ) and increased Annexin V staining (Fig. 3C) , indicative of programmed cell death. Despite selectively regulating commensal bacteria-specific CD4 + T cells in the steady state, MHCII + ILC3s were also sufficient to influence T cells with other antigen specificities only if antigen was exogenously provided (fig. S10) .
Negative selection in the thymus has been shown to be associated with induction of Nur77 and up-regulation of the proapoptotic molecule Bim (35) , which together mediate clonal deletion. Presentation of antigen by MHCII + ILC3s also resulted in the up-regulation of Nur77 and Statistical analyses between patient groups were performed using a Mann-Whitney test. *P < 0.05; **P < 0.01; ***P < 0.001. Correlative analyses were compared by parametric Pearson's rank correlation coefficient (r).
Bim by CBir1 CD4 + T cells, the latter of which was required for ILC3-mediated induction of T cell death (Fig. 3D-G) . Antigen presentation by ILC3s in vitro selectively led to T eff death but did not affect T reg numbers ( fig. S11A ). We next analyzed mLN-derived CCR6 + ILC3 for expression of surface molecules that directly influence antigen-specific CD4 + T cell responses (Fig. 3H ). ILC3s demonstrated high levels of MHCII-associated transcripts but had negligible expression of transcripts for canonical costimulatory molecules and inhibitory or death receptors (Fig. 3H) . Indeed, CCR6 + ILC3s lacked expression of FasL by flow cytometry, and antibody-mediated neutralization of FasL did not influence ILC3-induced CBir1 T cell death ( fig. S11, B to D) . Moreover, in contrast to Bim −/− mice, fasl gld/gld mice did not exhibit increased frequencies of endogenous commensal bacteria-specific CD4 + T cells in gutassociated lymphoid tissues ( fig. S11E) .
Bim-dependent apoptotic cell death may also be induced via cytokine or growth factor starvation (36, 37) . Because CCR6 + ILC3s constitutively express high levels of the common gamma chain cytokine receptors CD25 (IL-2R) and CD127 (IL7Ra) (Fig. 1, fig. S1 and Fig. 3H ), we hypothesized that MHCII + ILC3s may induce cell death of commensal bacteria-specific CD4 + T cells synergistically through TCR induction of an apoptotic program in concert with cytokine withdrawal. Consistent with this, cell death could be reduced upon addition of exogenous recombinant (r)IL-2, but not rIL-7, to in vitro cocultures (Fig. 3I) . MHCII + ILC3s exhibited more than twofold higher capacity to bind IL-2 as compared with activated CBir1 CD4 + T cells ( fig. S11 , F and G), suggesting that MHCII + ILC3s outcompete activated T cells for prosurvival cytokines. The requirement for IL-2 was T cell-intrinsic as activated CBir1 CD4 + T cells expressing a constitutively active STAT-5 molecule (S5CA) were resistant to Bim up-regulation and ILC3-induced cell death in vitro and in vivo (Fig. 3, J to L, and fig. S11 , H and I). Taken together, these data indicate that MHCII + ILC3s mediate a negative selection process through antigen presentation and withdrawal of IL-2 from the local milieu, resulting in deletion of activated commensal bacteriaspecific T cells.
Inflammatory CD4 + T cell responses against commensal bacteria are causally associated with the pathogenesis of IBD (7) (8) (9) (10) (11) . Furthermore, inflammatory T cells derived from Crohn's disease patients also exhibit reduced Bim-mediated cell death and cytokine-withdrawal-mediated apoptosis (38, 39) . Therefore, we next examined whether ILC3-intrinsic MHCII may be dysregulated in the context of human IBD. Using a previously defined gating strategy (40) , all ILC subsets could be identified in intestinal biopsies of pediatric Crohn's disease patients (Fig. 4A) (Fig. 4B) .
Although no alterations in the total frequency of ILC3s were observed between patient cohorts ( fig. S12C ), MHCII expression was significantly reduced on ILC3s (Fig. 4, C 4F ) and circulating commensal bacteria-specific immunoglobulin G (IgG) titers (Fig. 4G ) in pediatric Crohn's disease patients. Taken together, these data indicate that alterations in MHCII on human ILC3s are associated with proinflammatory adaptive immune cell responses to commensal bacteria. The mammalian gastrointestinal tract is colonized with trillions of beneficial commensal bacteria that regulate host nutrient metabolism and immune cell homeostasis and protect from pathogen infection (7, 11, 15) . As such, commensal bacteria are an essential component of the mammalian "superorganism" required for the host to thrive (41) . It is well characterized that self-specific CD4 + T cells with the potential to cause pathologic inflammation in mammalian tissues are controlled through antigen-dependent thymic selection (1) (2) (3) (4) (5) . Here, MHCII-expressing CCR6 + ILC3s were found to control intestinal homeostasis through induction of apoptotic cell death and deletion of activated commensal bacteria-specific T cells, a process with multiple similarities to negative selection in the thymus, which we propose to term intestinal selection ( fig. S13 ). Thus, intestinal selection controls the peripheral commensal bacteria-specific CD4 + T cell pool in concert with other previously described tolerogenic pathways, including T reg , production of IgA, and active maintenance of intestinal barrier function (7, 15, 17, 23) . Dysregulated ILC3-intrinsic MHCII in pediatric Crohn's disease patients suggests a possible role for alterations in this pathway in the onset and/ or progression of human IBD. Thus, MHCII + ILC3 may represent a novel therapeutic target to control pathologic CD4 + T cell responses in chronic human inflammatory disorders associated with dysregulated host-commensal bacteria relationships (7, 10, 15) .
